Listar por autoría "02a0d3ef-da6c-4e4b-a2b8-2a09546f97b5"

Mostrando ítems 1-2 de 2

    • openAccess   Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients’ biofluids: Potential role in disease diagnosis and management 

      Tomás Pérez, Sarai; Oto, Julia; AGHABABYAN, KRISTINA; Herranz, Raquel; Cuadros Lozano, Aitor; González Cantó, Eva; Mc Cormack, Bárbara Andrea; Arrés, Judith; Castano, Maria; Cana, Fernando; Martínez Fernández, Laura; Santonja, Núria; Ramírez, Rocío; Herreros Pomares, Alejandro; Cañete Mota, Sarai; Llueca, Antoni; Marí-Alexandre, Josep; Medina, Pilar; Gilabert-Estellés, Juan Frontiers Media (2023)
      Introduction: High-grade serous ovarian cancer (HGSOC) is the second most frequent gynecological malignancy but the most lethal, partially due to the spread of the disease through the peritoneal cavity. Recent evidence has ...

    • openAccess   Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study 

      Llueca, Antoni; Ibáñez Gual, Maria Victoria; CASCALES SANCHEZ, PEDRO; Gil-Moreno, Antonio; Bebia, Vicente; Ponce, Jordi; Fernandez, Sergi; Arjona-Sanchez, Alvaro; Muruzabal Torquemada, Juan Carlos; Veiga-Canuto, Nadia; Díaz-Feijoo, Berta; Celada Castro, Cristina; Gilabert-Estellés, Juan; AGHABABYAN, KRISTINA; Lacueva, Francisco Javier; Calero, Alicia; Segura-Sampedro, Juan José; Maiocchi, Karina; Llorca Cardeñosa, Sara; Villarín, Álvaro; CLIMENT MARTÍ, MARIA TERESA; Delgado Barriga, Katty; Serra Rubert, Anna; GOMEZ QUILES, LUIS; Llueca, Maria; Spain GOG and GECOP Working Group MDPI (2023-08-26)
      Simple Summary Advanced ovarian cancer (Stages III-IV) continues to be one of the gynecological tumors with the highest mortality. Standard treatment consists of debulking surgery and subsequent adjuvant chemotherapy. ...